These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12518020)

  • 21. [Cholesterol ester transfer protein. A major player in cholesterol metabolism].
    Hansen PR
    Ugeskr Laeger; 1999 Sep; 161(38):5295-8. PubMed ID: 10536513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport.
    Zhang Z; Yamashita S; Hirano K; Nakagawa-Toyama Y; Matsuyama A; Nishida M; Sakai N; Fukasawa M; Arai H; Miyagawa J; Matsuzawa Y
    Atherosclerosis; 2001 Nov; 159(1):67-75. PubMed ID: 11689208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.
    Barter PJ; Brewer HB; Chapman MJ; Hennekens CH; Rader DJ; Tall AR
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):160-7. PubMed ID: 12588754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.
    Zhou H; Li Z; Silver DL; Jiang XC
    Biochim Biophys Acta; 2006 Dec; 1761(12):1482-8. PubMed ID: 17055779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein.
    Dinchuk J; Hart J; Gonzalez G; Karmann G; Schmidt D; Wirak DO
    Biochim Biophys Acta; 1995 Apr; 1255(3):301-10. PubMed ID: 7734447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
    Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies.
    Tall AR
    J Intern Med; 1995 Jan; 237(1):5-12. PubMed ID: 7830031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
    J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels.
    Masucci-Magoulas L; Plump A; Jiang XC; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Jan; 97(1):154-61. PubMed ID: 8550828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cholesterol ester transfer protein (CETP)].
    Nakaya N
    Nihon Rinsho; 1994 Dec; 52(12):3164-9. PubMed ID: 7853706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-expression of cholesteryl ester transfer protein and defective apolipoprotein E in transgenic mice alters plasma cholesterol distribution. Implications for the pathogenesis of type III hyperlipoproteinemia.
    Fazio S; Marotti KR; Lee YL; Castle CK; Melchior GW; Rall SC
    J Biol Chem; 1994 Dec; 269(51):32368-72. PubMed ID: 7798236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.
    Gautier T; Masson D; Jong MC; Pais de Barros JP; Duverneuil L; Le Guern N; Deckert V; Dumont L; Bataille A; Zak Z; Jiang XC; Havekes LM; Lagrost L
    Biochem J; 2005 Jan; 385(Pt 1):189-95. PubMed ID: 15339254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits.
    Okamoto H; Yonemori F; Wakitani K; Minowa T; Maeda K; Shinkai H
    Nature; 2000 Jul; 406(6792):203-7. PubMed ID: 10910363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
    Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
    Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
    Hayek T; Chajek-Shaul T; Walsh A; Agellon LB; Moulin P; Tall AR; Breslow JL
    J Clin Invest; 1992 Aug; 90(2):505-10. PubMed ID: 1644921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2001 Feb; 42(2):241-8. PubMed ID: 11181754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo effects of CETP inhibitory peptides in hypercholesterolemic rabbit and cholesteryl ester transfer protein-transgenic mice.
    Cho KH; Shin YW; Choi MS; Bok SH; Jang SH; Park YB
    J Biochem Mol Biol; 2002 Mar; 35(2):172-7. PubMed ID: 12297026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.